About Wellth
Wellth is a digital health company that transforms healthcare outcomes by building daily relationships between health plans and their members. The platform uses behavioral economics principles and structured rewards to drive medication adherence, care plan compliance, and quality metric improvements across diverse populations. Members receive personalized daily reminders for essential health tasks like taking medications or checking blood glucose, then verify compliance through simple photo uploads in the Wellth app. Consistent engagement unlocks meaningful financial incentives that address social determinants of health. The company serves Medicare Advantage and D-SNP plans, Medicaid programs, healthcare providers, employers, and ACA Marketplace plans. Wellth's approach has been validated through randomized controlled trials and delivers proven outcomes including 90% average care plan adherence, 2-4x ROI on cost of care reduction, and 43% average reduction in high-cost utilization. The platform integrates seamlessly within existing workflows, requires no additional devices, and can be implemented in 30 days. Founded by CEO Matthew Loper after witnessing the profound impact of care plan adherence on family members with type 2 diabetes, Wellth is committed to empowering individuals with the motivation and support needed to follow their care plans and build lasting healthy habits.
Mission & Story
Mission
Our mission is to improve healthcare by helping members daily
Founding Story
Wellth's mission is deeply personal to CEO Matthew Loper, who saw firsthand how adherence to a care plan can change lives when his aunt and uncle were both diagnosed with type 2 diabetes. One embraced their treatment—taking medication, monitoring glucose, and adjusting their diet—and thrived. The other, despite best efforts, struggled to stay on track, faced serious complications, and ultimately passed away. This experience shaped Wellth's commitment to empowering individuals with the motivation and support they need to follow their care plans.
Clinical Focus
Medical conditions and clinical areas addressed by Wellth.
Who It Serves
Milestones & Awards
Recent Milestones
Over 70 million daily check-ins completed. Platform serving complex chronic, rising risk, and healthy populations simultaneously across multiple lines of business.
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.